Juno Therapeutics, Inc. — Revenue by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8bc54af6-5bf4-4a0f-b153-2944b928fcc5/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2017 | $111.9M | 2017-01-01 – 2017-12-31 | evidence 0001594864-18-000005 |
| FY 2016 | $79.4M | 2016-01-01 – 2016-12-31 | evidence 0001594864-17-000009 |
| FY 2015 | $18.2M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-485620 |
| FY 2014 | $0 | 2014-01-01 – 2014-12-31 | evidence 0001594864-17-000009 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Juno Therapeutics, Inc. — all facts · Net Income · Operating Income